Mendine Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.11 M
as on 24-10-2024
- Company Age 48 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.95 Cr
as on 24-10-2024
- Revenue 6.09%
(FY 2023)
- Profit 104.89%
(FY 2023)
- Ebitda 66.44%
(FY 2023)
- Net Worth 26.68%
(FY 2023)
- Total Assets 9.72%
(FY 2023)
About Mendine Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.11 M.
The company currently has active open charges totaling ₹15.95 Cr.
Probhas Chakraborty, Kalpana Chakraborty, Biswanath Paul, and Two other members serve as directors at the Company.
- CIN/LLPIN
U91397WB1975PTC030363
- Company No.
030363
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 1975
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mendine Pharmaceuticals Pvt Ltd offer?
Mendine Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics.
Who are the key members and board of directors at Mendine Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Probhas Chakraborty  | Director | 10-Dec-2004 | Current |
| Kalpana Chakraborty | Director | 01-Mar-2005 | Current |
| Biswanath Paul | Director | 02-Apr-2018 | Current |
| Srijani Lahiri | Director | 25-Jan-2022 | Current |
| Pulak Nag | Director | 01-Feb-2022 | Current |
Financial Performance of Mendine Pharmaceuticals.
Mendine Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 6.09% increase. The company also saw a substantial improvement in profitability, with a 104.89% increase in profit. The company's net worth Soared by an impressive increase of 26.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mendine Pharmaceuticals?
In 2023, Mendine Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mendine Lifecare Products Private LimitedActive 14 years 10 monthsProbhas Chakraborty, Kalpana Chakraborty and 1 more are mutual person
- Mendine Erythronet Private LimitedActive 9 years 7 months
Probhas Chakraborty, Kalpana Chakraborty and 1 more are mutual person
Inner Eye Consultancy Services LlpActive 5 years 2 monthsProbhas Chakraborty and Kalpana Chakraborty are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Jun 2024 | ₹3.09 M | Open |
Hdfc Bank Limited Creation Date: 17 Dec 2023 | ₹1.05 Cr | Open |
Canara Bank Creation Date: 30 Jan 2021 | ₹1.31 M | Open |
How Many Employees Work at Mendine Pharmaceuticals?
Mendine Pharmaceuticals has a workforce of 72 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mendine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mendine Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
